Press/Media
- 75 - 100 out of 170 results
Search results
-
Dalhousie researchers dye Halifax Harbour for climate change study
8/10/23
1 item of Media coverage
Press/Media: Research
-
-
Next Open Dialogue Live to explore how Dal researchers and partners are advancing climate‑focused ocean research
4/5/23
1 item of Media coverage
Press/Media: Research
-
Ocean Carbon Removal Research at Dalhousie University Funded by Carbon to Sea Initiative
6/14/23
1 item of Media coverage
Press/Media: Research
-
For Carbon-Capture Experiment, Researchers Dye Canada’s Halifax Harbor Pink – Slashdot
8/12/23
2 items of Media coverage
Press/Media: Research
-
Open Dialogue Live: The pandemic's impact on nature
5/26/20
1 item of Media coverage
Press/Media: Research
-
Researchers at Dalhousie University Have Published New Data on Alzheimer Disease (No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer's disease)
1/10/23
1 item of Media coverage
Press/Media: Research
-
Data on Headache Reported by Sharlene Rozario and Colleagues (An Online Psychological Program for Adolescents and Young Adults With Headaches: Iterative Design and Rapid Usability Testing)
Patrick J., M., Lori, W. & Anna, H.
12/27/23
1 item of Media coverage
Press/Media: Research
-
World-First Trial of Gene Therapy To Cure Form of Deafness Begins
10/12/23
2 items of Media coverage
Press/Media: Research
-
Gene therapy trial begins in children born with rare genetic deafness
10/23/23
1 item of Media coverage
Press/Media: Research
-
Some children born deaf in China finally able to hear after gene therapy, report says
11/1/23
5 items of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $840.14) accelerates rise: up 5% in 2 weeks; +$25.28 [3.1%]
12/9/23
1 item of Media coverage
Press/Media: Research
-
-
UK hospital launches world-first gene therapy trial to cure rare deafness
10/12/23 → 10/13/23
2 items of Media coverage
Press/Media: Research
-
Regeneron Shares Preliminary Results Showing Gene Therapy Improves Auditory Responses In Child With Profound Genetic Hearing Loss
10/26/23 → 10/27/23
63 items of Media coverage
Press/Media: Research
-
Bonds Weekly: Regeneron Pharmaceuticals Inc bonds bonds post worst week in s
12/25/23
1 item of Media coverage
Press/Media: Research
-
New Trials Aim to Restore Hearing in Deaf Children—With Gene Therapy
10/20/23
2 items of Media coverage
Press/Media: Research
-
Regeneron Shares Preliminary Results Showing Gene Therapy Improves Auditory Responses in Child with Profound Genetic Hearing Loss
10/27/23
1 item of Media coverage
Press/Media: Research
-
First Ever Trial of Gene Therapy for Auditory Neuropathy Kicks Off
10/15/23
1 item of Media coverage
Press/Media: Research
-
Doctors Testing Gene Therapy to Cure a Type of Deafness
10/15/23
2 items of Media coverage
Press/Media: Research
-
Australia Patent for 'Subcutaneous piezoelectric bone conduction hearing aid actuator and system' Ceases
Jeremy A., B. & Manohar Lal, B.
1/8/21
1 item of Media coverage
Press/Media: Research
-
Regeneron Shares Preliminary Results Showing Gene Therapy Improves Auditory Responses in Child with Profound Genetic Hearing Loss
10/26/23 → 10/27/23
4 items of Media coverage
Press/Media: Research
-
Monthly: Regeneron (REGN: $823.81) adds $5 billion in MCap in November, leads Medical/Biomedical sector gains
11/30/23
1 item of Media coverage
Press/Media: Research
-
Some children born deaf in China finally able to hear after gene therapy, report says
11/1/23
1 item of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $775.18) shares post worst week in seventeen weeks; -$33.29 [4.1%]
10/28/23
1 item of Media coverage
Press/Media: Research